CVS Health Net Income 2010-2025 | CVS
CVS Health annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- CVS Health net income for the quarter ending March 31, 2025 was $1.779B, a 59.84% increase year-over-year.
- CVS Health net income for the twelve months ending March 31, 2025 was $5.280B, a 27.88% decline year-over-year.
- CVS Health annual net income for 2024 was $4.614B, a 44.7% decline from 2023.
- CVS Health annual net income for 2023 was $8.344B, a 93.55% increase from 2022.
- CVS Health annual net income for 2022 was $4.311B, a 46.12% decline from 2021.
| CVS Health Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $4,614 |
| 2023 | $8,344 |
| 2022 | $4,311 |
| 2021 | $8,001 |
| 2020 | $7,179 |
| 2019 | $6,634 |
| 2018 | $-594 |
| 2017 | $6,622 |
| 2016 | $5,317 |
| 2015 | $5,237 |
| 2014 | $4,644 |
| 2013 | $4,592 |
| 2012 | $3,864 |
| 2011 | $3,462 |
| 2010 | $3,427 |
| 2009 | $3,696 |
| CVS Health Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,779 |
| 2024-12-31 | $1,644 |
| 2024-09-30 | $87 |
| 2024-06-30 | $1,770 |
| 2024-03-31 | $1,113 |
| 2023-12-31 | $2,046 |
| 2023-09-30 | $2,261 |
| 2023-06-30 | $1,901 |
| 2023-03-31 | $2,136 |
| 2022-12-31 | $2,334 |
| 2022-09-30 | $-3,406 |
| 2022-06-30 | $3,029 |
| 2022-03-31 | $2,354 |
| 2021-12-31 | $1,397 |
| 2021-09-30 | $1,598 |
| 2021-06-30 | $2,783 |
| 2021-03-31 | $2,223 |
| 2020-12-31 | $973 |
| 2020-09-30 | $1,224 |
| 2020-06-30 | $2,975 |
| 2020-03-31 | $2,007 |
| 2019-12-31 | $1,747 |
| 2019-09-30 | $1,530 |
| 2019-06-30 | $1,936 |
| 2019-03-31 | $1,421 |
| 2018-12-31 | $-419 |
| 2018-09-30 | $1,390 |
| 2018-06-30 | $-2,563 |
| 2018-03-31 | $998 |
| 2017-12-31 | $3,287 |
| 2017-09-30 | $1,285 |
| 2017-06-30 | $1,098 |
| 2017-03-31 | $952 |
| 2016-12-31 | $1,707 |
| 2016-09-30 | $1,540 |
| 2016-06-30 | $924 |
| 2016-03-31 | $1,146 |
| 2015-12-31 | $1,498 |
| 2015-09-30 | $1,246 |
| 2015-06-30 | $1,272 |
| 2015-03-31 | $1,221 |
| 2014-12-31 | $1,321 |
| 2014-09-30 | $948 |
| 2014-06-30 | $1,246 |
| 2014-03-31 | $1,129 |
| 2013-12-31 | $1,265 |
| 2013-09-30 | $1,249 |
| 2013-06-30 | $1,124 |
| 2013-03-31 | $954 |
| 2012-12-31 | $1,116 |
| 2012-09-30 | $1,006 |
| 2012-06-30 | $966 |
| 2012-03-31 | $776 |
| 2011-12-31 | $1,065 |
| 2011-09-30 | $868 |
| 2011-06-30 | $816 |
| 2011-03-31 | $713 |
| 2010-12-31 | $1,026 |
| 2010-09-30 | $809 |
| 2010-06-30 | $821 |
| 2010-03-31 | $771 |
| 2009-12-31 | $1,051 |
| 2009-09-30 | $1,021 |
| 2009-06-30 | $886 |
| 2009-03-31 | $738 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $83.137B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.512B | 27.48 |
| Elevance Health (ELV) | United States | $86.065B | 11.11 |
| Cencora (COR) | United States | $55.558B | 19.33 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.771B | 0.00 |
| BioMerieux (BMXMF) | France | $16.981B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.266B | 0.00 |
| Solventum (SOLV) | United States | $12.874B | 13.63 |
| ICON (ICLR) | Ireland | $11.753B | 10.93 |
| CochLear (CHEOY) | Australia | $11.492B | 0.00 |
| Revvity (RVTY) | United States | $11.324B | 19.49 |
| Doximity (DOCS) | United States | $10.794B | 49.97 |
| Viatris (VTRS) | United States | $10.540B | 3.62 |
| Avantor (AVTR) | United States | $9.213B | 13.39 |
| HealthEquity (HQY) | United States | $9.042B | 39.61 |
| Medpace Holdings (MEDP) | United States | $8.689B | 23.08 |
| Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.422B | 14.54 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.425B | 26.06 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 35.31 |
| Sotera Health (SHC) | United States | $3.423B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.055B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Concentras Parent (CON) | United States | $2.811B | 16.24 |
| Organon (OGN) | United States | $2.620B | 2.78 |
| GeneDx Holdings (WGS) | United States | $2.006B | 77.28 |
| Ardent Health (ARDT) | United States | $1.908B | 8.13 |
| Progyny (PGNY) | United States | $1.859B | 40.92 |
| Premier (PINC) | United States | $1.853B | 14.06 |
| GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.302B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.29 |
| CareDx (CDNA) | United States | $1.118B | 17.46 |
| Establishment Labs Holdings (ESTA) | $1.114B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.844B | 7.90 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.671B | 10.16 |
| Embecta (EMBC) | United States | $0.591B | 3.98 |
| LifeMD (LFMD) | United States | $0.574B | 0.00 |
| Enhabit (EHAB) | United States | $0.519B | 42.71 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.255B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.252B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.109B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| OpGen (OPGN) | United States | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |